www.fdanews.com/articles/98292-the-netherlands-8217-crucell-signs-deal-with-merck-38-co
The Netherlands’ Crucell Signs Deal With Merck & Co
September 10, 2007
Crucell has been boosted by the news that drugs giant Merck & Co has exercised an option for the exclusive use of the Dutch firm’s PER.C6 technology.
Pharma Times